2022 | Participation in and withdrawal from cancer clinical trials: A survey of clinical research coordinators | 임경민; 김명규 | Article |
2022 | The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid-related diseases: An analysis of the national pharmacovigilance database in South Korea | 김명규 | Article |
2022 | MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11 | 송은주 | Article |
2022 | Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR | 송은주 | Review |
2022 | Fine-Tuning BERT Models to Classify Misinformation on Garlic and COVID-19 on Twitter | 김명규 | Article |
2022 | Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease | 김명규 | Article |
2022 | The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation | 이공주; 송은주 | Article |
2022 | Alcoholic liver disease: a new insight into the pathogenesis of liver disease | 서원효 | Review |
2022 | Effects of intermediate frequency electromagnetic fields: a review of animal studies | 이윤실; 진희 | Review |
2022 | Gray matter volume reduction in the emotional brain networks in adults with anosmia | 류인균; 김정윤; 이수지; 하은지 | Article |
2022 | Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy | 김광명 | Article |
2022 | Evaluation of Skin Irritation of Acids Commonly Used in Cleaners in 3D-Reconstructed Human Epidermis Model, KeraSkin (TM) | 임경민; 황지현 | Article |
2022 | Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1 | 이윤실; 문길임 | Article |
2022 | MARTX toxin of Vibrio vulnificus induces RBC phosphatidylserine exposure that can contribute to thrombosis | 임경민; 김병식 | Article |
2022 | Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy | 김광명 | Article |
2022 | Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity | 김광명 | Article |
2022 | Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy | 김광명 | Article |
2022 | Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity | 김광명 | Article |
2022 | Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light | 김광명 | Article |
2022 | Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models | 김광명 | Article |